Overview

Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-02-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of CHF6001 (Tanimilast) as add-on to maintenance of inhaled corticosteroids in combination with Long-acting ß2-agonists in the target patient population. (TANGO)
Phase:
PHASE2
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.